IFNG and neoplasm: Importantly, in the context of neoadjuvant therapy, it is a potent activator of both NK and T cell IFN-γ production,45 has been demonstrated to have antiangiogenic properties46 and can also upregulate cellular expression of MHCI and MHCII molecules,47 facilitating presentation of tumor antigens important for long-term disease surveillance.